Invention Grant
- Patent Title: Crystalline form of N-butyldeoxygalactonojirimycin
-
Application No.: US16618036Application Date: 2018-05-31
-
Publication No.: US11306058B2Publication Date: 2022-04-19
- Inventor: Vitor Oliveira , Ivan Pogorelic , Jean-Paul Roduit
- Applicant: IDORSIA PHARMACEUTICALS LTD
- Applicant Address: CH Allschwil
- Assignee: IDORSIA PHARMACEUTICALS LTD
- Current Assignee: IDORSIA PHARMACEUTICALS LTD
- Current Assignee Address: CH Allschwil
- Agency: Hoxie & Associates LLC
- Priority: WOPCT/EP2017/063287 20170601
- International Application: PCT/EP2018/064365 WO 20180531
- International Announcement: WO2018/220131 WO 20181206
- Main IPC: C07D211/40
- IPC: C07D211/40 ; C07D211/46 ; A61K9/48 ; A61P3/06 ; A61P43/00 ; A61P25/00 ; A61P35/00 ; A61K31/445
Abstract:
The invention relates to a crystalline form of [(2R,3S,4R,5S)-1-butyl-2-(hydroxymethyl)-piperidine-3,4,5-triol, processes for the preparation thereof, pharmaceutical compositions containing such a crystalline form, and its use as a medicament, especially as glycolipid biosynthesis inhibitor.
Information query
